Аннотация

Цель
Wolf-Parkinson-White syndrome (WPW) is a relatively common electrophysiological arrhyth-mia characterized by an additional atrioventricular conduction known as the Kent bundle. This ab-normal connection enables premature ventricular excitation, leading to the development of various tachyarrhythmias, including paroxysmal supraventricular tachycardia. WPW syndrome often re-mains asymptomatic; however, some patients may experience palpitations, dizziness, syncopal epi-sodes (fainting), and, in rare cases, life threatening arrhythmias. Therefore, timely diagnosis, risk stratification, and the selection of optimal therapy are crucial for improving the prognosis and quality of life of patients with WPW syndrome. This review provides an analysis of contemporary diagnostic criteria, risk assessment methods, and therapeutic strategies for WPW syndrome.

Ключевые слова

Wolf-Parkinson-White syndrome (WPW) electrocardiography electrophysiological study (EPS) ablation

Полный текст

Скачать статью в PDF

Полная версия статьи в формате PDF

Список литературы

  1. Арингазина Р.А., Мусина А.З., Жолдасова Н.Ж., Дильмагамбетова Г.С., Сейтмаганбето-ва Н.А., Бхат С. Особенности патогенеза, диагностики и катетерной аблации синдрома Вольфа-Паркинсона-Уайта // Кардиологический вестник. 2023; Т. 18, №3: С. 29–34.
  2. Заглиева С.С., Маммаев С.Н., Заглиев С.Г. Пароксизмальные нарушения ритма сердца при синдроме Вольфа-Паркинсона-Уайта // Вестник Дагестанской государственной медицинской академии. 2021; № 1(38): С. 55–62.
  3. Пеняева Е.В. Генетические аспекты аномалии Эбштейна и связанных с ней заболеваний сердца // Вестник РАМН. 2021; Т. 76, №1: С. 67–74.
  4. Саматкызы Д., Акильжанова А.Р. Генетические аспекты нарушения ритма и проводимости сердца (обзор литературы) // Вестник Казахского Национального медицинского университета. 2020; №3: С. 54–62.
  5. Толстокорова Ю.А., Никулина С.Ю., Чернова А.А. Соматометрическая характеристика пациентов с синдромом Вольфа-Паркинсона-Уайта // Российский кардиологический журнал. 2024; Т. 29, №10: С. 90-94.
  6. Толстокорова Ю.А., Никулина С.Ю., Чернова А.А., Максимов В.Н., Макаров Я.А. Исследование генов PRKAG2 и PRKAG3 у пациентов с синдромом Вольфа-Паркинсона-Уайта // Российский кардиологический журнал. 2023; Т. 28, №10: С. 53-56.
  7. Толстокорова Ю.А., Никулина С.Ю., Чернова А.А. Клиническая, электрофизиологическая, молекулярно-генетическая характеристика пациентов с синдромом Вольфа-Паркинсона-Уайта (обзор литературы) // CardioСоматика. 2023; Т. 14, №1: С. 59–66. DOI: 10.17816/CS134114.
  8. Apfel G., Choi N.H., Silver E.S., et al. Assessing the utility of atrial fibrillation induction to risk stratify children with Wolff-Parkinson-White syndrome. Cardiol Young. 2023, Vol. 13, pp. 1–5.
  9. Barat M., Barba D.T., Ho G., et al. Wolff-Parkinson-White syndrome: Diagnostic and management strategies. Cleve Clin J Med. 2025, Vol. 92, No. 2, pp. 119-127.
  10. Brado J., Hochadel M., Senges J., et al. Outcomes of ablation in Wolff-Parkinson-White syndrome: Data from the German Ablation Registry. Int J Cardiol. 2020, Vol. 323, pp. 106–112.
  11. Brugada J., Katritsis D.G., Arbelo E., et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardia. European Heart Journal. 2020, Vol. 41, No. 5, pp. 655–720.
  12. Coban-Akdemir Z.H., Charng W., Azamian M., et al. Wolff-Parkinson-White syndrome: De novo variants and evidence for mutational burden in genes associated with atrial fibrillation. Am J Med Genet Part A. 2020, Vol. 182, pp. 1387–1399.
  13. Daniels S.R., Wolff-Parkinson-White pattern and risk of sudden death. J Pediatrics. 2019, Vol. 213, pp. 1–3.
  14. Delise P., Sciarra L., Sudden Cardiac Death in Patients with Ventricular Preexcitation. Card Electrophysiol Clin. 2020, Vol. 12, pp. 519–525.
  15. Di Pino A., Oreto L., Di Pino A., et al. Electrophysiological guided accessory pathway ablation strategy in children with asymptomatic WPW: It may not be enough to prevent sudden cardiac death. J Interv Card Electrophysiol. 2023, Vol. 66, No. 5, pp. 1125–1133.
  16. El Hamriti M., Braun M., Molatta S., et al. EASY-WPW: A novel ECG-algorithm for easy and reliable localization of manifest accessory pathways in children and adults. Europace. 2022, Vol. 25, pp. 600–609.
  17. Escudero C.A., Ceresnak S.R., Collins K.K., et al. Loss of ventricular preexcitation during non-invasive testing does not exclude high-risk accessory pathways: A multicenter study of WPW in children. Heart Rhythm. 2020, Vol. 17, pp. 1729–1737.
  18. Etheridge S.P., Gakenheimer-Smith L., Asaki S.Y., et al. Asymptomatic Wolff-Parkinson-White Syndrome: An Ounce of Prevention Is Worth the Risk of Cure. Curr Cardiol Rep. 2023, Vol. 25, pp. 543–551.
  19. Grubb C.S., Lewis M., Whang W., et al. Catheter ablation for atrial tachycardia in adults with congenital heart disease: Electrophysiological predictors of acute procedural success and post-procedure atrial tachycardia recurrence. JACC Clin Electrophysiol. 2019, Vol. 5, No. 4, pp. 438–447.
  20. Ibrahim A., Abdelaal S.A., Hasan M.T., et al. The success rate of radiofrequency catheter ablation in Wolff-Parkinson-White Syndrome patients: A systematic review and meta-analysis. Indian Heart J. 2023, Vol. 75, No. 2, pp. 98–107. doi: 10.1016/j.ihj.2023.02.001.
  21. Jemtrén A., Saygi S., Åkerström F., et al. Risk assessment in patients with symptomatic and asymptomatic pre-excitation. Europace. 2024, Vol. 26, No. 2, pp. euae036.
  22. Khairy P., Van Hare G.F., Balaji S., et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease. Can J Cardiol. 2014, Vol. 30, pp. e1–e63.
  23. Koneru J.N., Wood M.A., Ellenbogen K.A., et al. Rare forms of preexcitation: A case study and brief overview of familial forms of preexcitation. Circ Arrhythm Electrophysiol. 2012, Vol. 5, pp. 82–88. doi: 10.1161/CIRCEP.111.968917.
  24. Miyamoto L. Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome: Molecular mechanisms of cardiac glycogen regulation by AMPK. J Med Invest. 2018, Vol. 65, No. 1–2, pp. 1–8.
  25. Nunes A., Lebreiro A., Campelo M., et al. Iatrogenic ventricular fibrillation in Wolff-Parkinson-White syndrome. Rev Port Cardiol. 2022, Vol. 41, No. 11, pp. 973.e1–973.e4.
  26. Pambrun T., El Bouazzaoui R., Combes N., et al. Maximal pre-excitation based algorithm for localization of manifest accessory pathways in adults. JACC Clin Electrophysiol. 2018, Vol. 4, pp. 1052–1061.
  27. Pappone C., Santinelli V., Manguso F., et al. A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med. 2003, Vol. 19, pp. 1803–1814.
  28. Raposo D., António N., Andrade H., et al. Management of asymptomatic Wolff-Parkinson–White pattern in young patients: Has anything changed? Pediatr Cardiol. 2019, Vol. 40, pp. 892–900.
  29. Rudic B., Borggrefe M. Historische Entwicklungen in Diagnostik und Therapie bei Präexzitationssyndromen (WPW) [Historical developments in the diagnosis and treatment of pre-excitation syndromes (WPW)]. Herzschrittmacherther Elektrophysiol. 2024, Vol. 35(Suppl. 1), pp. 118–126.
  30. Schiavone M., Filtz A., Gasperetti A., et al. Pre-excited atrial fibrillation in Wolff-Parkinson-White (WPW) syndrome: A case report and review of literature. Rev Cardiovasc Med. 2024, Vol. 25, No. 4, pp. 125.
  31. Sherdia A.F.I.A., Abdelaal S.A., Hasan M.T., et al. The success rate of radiofrequency catheter ablation in Wolff-Parkinson-White syndrome patients: A systematic review and meta-analysis. Indian Heart J. 2023, Vol. 75, pp. 98–107.
  32. Skov M.W., Rasmussen P.V., Ghouse J., et al. Electrocardiographic preexcitation and risk of cardiovascular morbidity and mortality: Results from the Copenhagen ECG study. Circ Arrhythm Electrophysiol. 2017, Vol. 10, pp. e004778.
  33. Vătășescu R.G., Paja C.S., Șuș I., et al. Wolf-Parkinson-White syndrome: Diagnosis, risk assessment, and therapy—an update. Diagnostics (Basel). 2024, Vol. 14, No. 3, pp. 296.
  34. Vijay Y., Sanjeev T., Mani G.R., et al. A Wolff-Parkinson-White (WPW) electrocardiographic pattern in asymptomatic patient—state-of-the-art review. J Cardiol Cardiovasc Med. 2022, Vol. 7, pp. 45–52.
  35. Zhang Y., Xin M., Liu T., et al. The effect of accessory pathway location on cardiac function in adult patients with Wolff-Parkinson-White syndrome. Cardiol Res Pract. 2021, Vol. 2021, pp. е8841736.